Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000684794 | SCV000551228 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568144 | SCV000673934 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-15 | criteria provided, single submitter | clinical testing | The p.T269S variant (also known as c.806C>G), located in coding exon 4 of the MSH6 gene, results from a C to G substitution at nucleotide position 806. The threonine at codon 269 is replaced by serine, an amino acid with similar properties. This alteration has been reported as an alteration of unknown clinical significance in a Danish Lynch syndrome cohort (Nilbert M et al, Fam. Cancer 2009 ; 8(1):75-83). It has also been reported as an uncertain variant in two individuals from a cohort of 815 patients with suspicion for HNPCC (Okkels H et al, Appl. Immunohistochem. Mol. Morphol. 2012 Oct; 20(5):470-7). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759873 | SCV000889507 | uncertain significance | not provided | 2017-09-15 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000568144 | SCV001344140 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-21 | criteria provided, single submitter | clinical testing | This missense variant replaces threonine with serine at codon 269 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual affected with endometrial cancer whose tumor displayed high microsatellite instability and mismatch repair deficiency (PMID: 33693762). This variant has been also been reported in several families suspected of Lynch syndrome (PMID: 18566915, 22495361). This variant has been identified in 3/251032 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Gene |
RCV000759873 | SCV002499819 | uncertain significance | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Observed in individuals with a history of Lynch syndrome associated cancers (Nilbert 2009, Okkels 2012); This variant is associated with the following publications: (PMID: 18566915, 22290698, 26333163, 22495361, 23621914, 32123317, 21437237) |
Center for Genomic Medicine, |
RCV002267836 | SCV002552284 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504983 | SCV002814849 | uncertain significance | Endometrial carcinoma; Lynch syndrome 5; Mismatch repair cancer syndrome 3 | 2022-04-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997104 | SCV004837041 | uncertain significance | Lynch syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing | This missense variant replaces threonine with serine at codon 269 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual affected with endometrial cancer whose tumor displayed high microsatellite instability and mismatch repair deficiency (PMID: 33693762). This variant has been also been reported in several families suspected of Lynch syndrome (PMID: 18566915, 22495361). This variant has been identified in 3/251032 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |